跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 1,700 条关于
“MannKind Corporation”
全部
1,700
临床试验
179
药物
98
机构
466
资讯
957
3个月前
MannKind Corporation Receives FDA Approval for Afrezza Inhaled Insulin in Pediatric Diabetes Patients
去年
MannKind Secures $500 Million Strategic Financing from Blackstone to Advance Inhaled Therapeutics Pipeline
去年
MannKind and United Therapeutics Expand Partnership for Second Pulmonary Hypertension Inhaled Therapy
去年
MannKind Prepares to Present Pediatric Inhaled Insulin Data at ADA Scientific Sessions
11个月前
MannKind Appoints Dr. Ajay Ahuja as Chief Medical Officer to Advance Inhaled Therapeutics Pipeline
去年
MannKind Acquires scPharmaceuticals for Up to $360M to Expand Cardiorenal Portfolio
去年
MannKind Initiates Phase 3 Trial of Clofazimine Inhalation Suspension for NTM Lung Disease
10个月前
MannKind Discontinues Phase 3 Trial of Nebulized Clofazimine for NTM Lung Disease Due to Futility
去年
Afrezza Shows Non-Inferiority to Insulin Injections in Pediatric Diabetes Trial
2个月前
FDA Approves MannKind's Furoscix ReadyFlow, the First Autoinjector for IV-Equivalent Diuretic Therapy in Heart Failure and CKD
第 1 页,共 96 页
上一页
下一页